OBJECTIVE: Interleukin-6 (IL-6) and C-reactive protein (CRP) are markers of systemic vascular inflammation that herald atherothrombosis and may have important interrelationships with traditional cardiovascular risk factors. METHODS AND RESULTS: We conducted a cross-sectional analysis among 340 apparently healthy women enrolled in the Women's Health Study. In unadjusted analyses, higher levels of IL-6 and CRP were seen with increasing body mass index (BMI), systolic and diastolic blood pressure, and smoking exposure. IL-6 levels were related to the frequency of alcohol intake (P=0.002) and showed an inverse relationship with exercise frequency and hormone replacement therapy (P<0.0001 for both). CRP levels increased with hormone replacement therapy (P=0.0002). Associations among IL-6, CRP, and lipid levels were minimal. Overall, mean levels of IL-6 and CRP increased with increasing numbers of clinical risk factors (P<0.0001). In multivariate analyses, independent relationships were seen between levels of IL-6 and age, BMI, smoking, systolic blood pressure, alcohol use, presence of diabetes, and frequency of exercise. CRP was associated with age, BMI, systolic blood pressure, high density lipoprotein, smoking, and hormone replacement therapy in adjusted analyses. CONCLUSIONS: Plasma levels of IL-6 and CRP are independently related to several clinical cardiovascular risk factors in women.
OBJECTIVE:Interleukin-6 (IL-6) and C-reactive protein (CRP) are markers of systemic vascular inflammation that herald atherothrombosis and may have important interrelationships with traditional cardiovascular risk factors. METHODS AND RESULTS: We conducted a cross-sectional analysis among 340 apparently healthy women enrolled in the Women's Health Study. In unadjusted analyses, higher levels of IL-6 and CRP were seen with increasing body mass index (BMI), systolic and diastolic blood pressure, and smoking exposure. IL-6 levels were related to the frequency of alcohol intake (P=0.002) and showed an inverse relationship with exercise frequency and hormone replacement therapy (P<0.0001 for both). CRP levels increased with hormone replacement therapy (P=0.0002). Associations among IL-6, CRP, and lipid levels were minimal. Overall, mean levels of IL-6 and CRP increased with increasing numbers of clinical risk factors (P<0.0001). In multivariate analyses, independent relationships were seen between levels of IL-6 and age, BMI, smoking, systolic blood pressure, alcohol use, presence of diabetes, and frequency of exercise. CRP was associated with age, BMI, systolic blood pressure, high density lipoprotein, smoking, and hormone replacement therapy in adjusted analyses. CONCLUSIONS: Plasma levels of IL-6 and CRP are independently related to several clinical cardiovascular risk factors in women.
Authors: Lisa K Sprod; Oxana G Palesh; Michelle C Janelsins; Luke J Peppone; Charles E Heckler; M Jacob Adams; Gary R Morrow; Karen M Mustian Journal: Community Oncol Date: 2010-10
Authors: J R Ortlepp; J Metrikat; K Vesper; V Mevissen; F Schmitz; M Albrecht; P Maya-Pelzer; P Hanrath; C Weber; K Zerres; R Hoffmann Journal: J Mol Med (Berl) Date: 2003-08-20 Impact factor: 4.599
Authors: Álvaro H Borges; Jemma L O'Connor; Andrew N Phillips; Frederikke F Rönsholt; Sarah Pett; Michael J Vjecha; Martyn A French; Jens D Lundgren Journal: J Infect Dis Date: 2015-02-26 Impact factor: 5.226
Authors: M Faraj; L Messier; J P Bastard; A Tardif; A Godbout; D Prud'homme; R Rabasa-Lhoret Journal: Diabetologia Date: 2006-05-03 Impact factor: 10.122
Authors: Ankita Misra; Matthew P Longnecker; Kathie L Dionisio; Riana M S Bornman; Gregory S Travlos; Sukhdev Brar; Kristina W Whitworth Journal: Environ Res Date: 2018-06-06 Impact factor: 6.498
Authors: Tess V Clendenen; Karen L Koenig; Alan A Arslan; Annekatrin Lukanova; Franco Berrino; Yian Gu; Goran Hallmans; Annika Idahl; Vittorio Krogh; Anna E Lokshin; Eva Lundin; Paola Muti; Adele Marrangoni; Brian M Nolen; Nina Ohlson; Roy E Shore; Sabina Sieri; Anne Zeleniuch-Jacquotte Journal: Cytokine Date: 2011-10-19 Impact factor: 3.861
Authors: David E Chiriboga; Yunsheng Ma; Wenjun Li; Edward J Stanek; James R Hébert; Philip A Merriam; Eric S Rawson; Ira S Ockene Journal: Clin Chem Date: 2009-02 Impact factor: 8.327
Authors: Jose R Castillo-Mancilla; Todd T Brown; Kristine M Erlandson; Frank J Palella; Edward M Gardner; Bernard J C Macatangay; Elizabeth C Breen; Lisa P Jacobson; Peter L Anderson; Nikolas I Wada Journal: Clin Infect Dis Date: 2016-09-22 Impact factor: 9.079
Authors: Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar Journal: Am J Physiol Heart Circ Physiol Date: 2019-02-01 Impact factor: 4.733